Related Experiment Video
Updated: May 15, 2026

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
Published on: October 6, 2023
A Paradigm Shift in Snakebite Envenoming Therapy: From Conventional Antivenoms to Rationally Designed, Broadly
Ning Shi1,2, Jie Wang2, Can Xu2
1Department of Neurosurgery, Xiangya Hospital, Xiangya School of Basic Medical Science, Central South University, Changsha, Hunan 410008, China.
Next-generation antivenoms using recombinant antibody engineering offer safer and more reliable snakebite treatments. Developing oligoclonal "cocktail" therapies is key for broad-spectrum venom neutralization.
Area of Science:
- Biotechnology
- Immunology
- Pharmacology
Background:
- Polyclonal antivenom, the current standard for snakebite therapy, faces limitations in safety, stability, and reliable production.
- These limitations necessitate the development of alternative, advanced therapeutic strategies for snakebite management.
Purpose of the Study:
- To review the advancements in next-generation antivenoms utilizing recombinant antibody engineering.
- To explore strategies for discovering and developing novel antivenom molecules.
- To advocate for oligoclonal "cocktail" therapies for broad-spectrum venom neutralization.
Main Methods:
- Systematic review of recombinant antibody engineering strategies, including humanized monoclonal antibodies, VHHs, and computationally designed proteins.
- Analysis of challenges in bioprocessing, formulation, and regulatory science for antivenom translation.
- Exploration of emerging technologies to accelerate antivenom development.
Main Results:
- Recombinant antibody engineering presents viable alternatives to traditional antivenoms.
- Oligoclonal "cocktail" therapies are proposed as a superior approach for neutralizing complex venoms.
- Significant challenges remain in manufacturing, formulation, and regulatory approval for widespread accessibility.
Conclusions:
- Next-generation antivenoms hold significant promise for improving snakebite treatment outcomes.
- A shift towards rationally designed oligoclonal therapies is crucial for effective, broad-spectrum venom neutralization.
- Overcoming bioprocessing, formulation, and regulatory hurdles is essential for global accessibility of these advanced antivenoms.
Related Concept Videos
Pharmaceutical Poisoning: Treatment Strategies
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Cross-reactivity
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...

